---
title: >-
  Ceo of Global Pharmaceutical Giant Merck, Ken Frazier, Speaking About a
  Potential Covid-19 Treatment.
slug: >-
  20200527-ceo-of-global-pharmaceutical-giant-merck-ken-frazier-speaking-about-a-potential-covid-19-treatment
_id: legacy-0bb06745-080c-46d2-be40-7d3fda4dee7a
_rev: gzsIxkhSGQWrSyyf7Hch3Z
type: quick_quotes
draft: false
aliases:
  - >-
    article/ceo-of-global-pharmaceutical-giant-merck-ken-frazier-speaking-about-a-potential-covid-19-treatment/
_createdAt: '2020-05-28T01:58:20Z'
_updatedAt: '2021-04-17T08:36:02Z'
date: '2020-05-28T01:58:20+00:00'
lastmod: '2020-05-28T01:58:20+00:00'
weight: 50
featured_image:
  alt: Featured article image
  url: >-
    a160e1c8cf8a07c5ac54f40757b568390b0a61b81880x1253.jpg
is_breaking: false
featured_quote:
  quote: >-
    We understand the urgency, but our goal isn’t to be the frontrunner in the
    early stages — it’s to develop a vaccine that is safe and effective.

---
* [Frazier](https://www.merck.com/about/leadership/board-of-directors/home.html) recently did a series of interviews as the company continues to push into the competitive space for a COVID-19 treatment.
* Merck recently bought a European company working on a COVID-19 vaccine.
* Merck also partnered with a smaller U.S. company working on an antiviral treatment for COVID-19; unlike remdesevir, this treatment does not have to be administered through an IV.
* **Why It Matters:** Frazier, although optimistic about COVID-19 pharmaceuticals, underscored the need for safety and efficiency when millions – and potentially billions – of people may eventually need the treatments developed. He said in an interview with _The Financial Times_ that 12-18 months to develop a safe and effective vaccine was “very aggressive” and a timeline he did not want to commit his company too.

Read more of his _Financial Times_ interview [HERE](https://www.ft.com/content/7b72a568-9eed-460f-b100-7bf74e3f4cbf)